American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting March 1, 2012

The AAAAI Annual Meeting will provide recent research and information that allows patients and healthcare professionals to make informed decisions regarding allergies, asthma and immune deficiency disorders. The five-day event includes a full-program of workshops, CME courses, poster sessions, educational symposia, and oral and abstract presentations related to the pathogenesis and treatment of allergic and immunologic disease.

MedImmune will present:

• "Meta-analysis of the Efficacy of Live Attenuated Influenza Vaccine in Children 2 through 17 Years of Age"
• "A post-licensure evaluation of the safety of live attenuated influenza vaccine in U.S. children 5–17 years of age"
• "Pediatric Influenza Vaccination by Office-based Pediatricians and Family Physicians During the 2010–2011 Influenza Season"
• "Interoffice Variability in the Delivery of Influenza Vaccine by US Pediatric Offices"
• "The Impact of Live Attenuated Influenza Vaccine on All-Cause Acute Otitis Media"
• "A Postlicensure Evaluation of the Safety of Live Attenuated Influenza Vaccine in Children 2 to 4 Years of Age"
• "Smaller Pediatric Offices Have Higher In-Office Influenza Vaccination Rates"
• "What is the Evidence Supporting the Development of Quadrivalent Influenza Vaccines? "
• "Do Influenza Illness Symptoms Differ Among Vaccinated And Unvaccinated Children? "
• "Improved timing of availability and administration of influenza vaccine through the Vaccines for Children program from 2007 to 2011"